- Investing Ideas
- /
- Chilean Pharmaceuticals & Biotech Potentially Undervalued Companies
Chilean Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
12
Companies with a Value score of at least 3, ordered by Value score
12 companies
Merck
Market Cap: CL$191.3b
Operates as a healthcare company worldwide.
MRKCL
CL$76,982.00
7D
0%
1Y
-36.1%
Merck
Market Cap: US$191.3b
Operates as a healthcare company worldwide.
MRK
US$76.66
7D
0%
1Y
-38.8%
Pfizer
Market Cap: US$131.8b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE
US$26.06
7D
0%
1Y
-9.8%
Amgen
Market Cap: CL$149.7b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGNCL
CL$293,440.00
7D
0%
1Y
11.7%
Gilead Sciences
Market Cap: CL$134.9b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILDCL
CL$79,000.00
7D
0%
1Y
n/a
Johnson & Johnson
Market Cap: US$366.8b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJ
US$148.27
7D
0%
1Y
0%
Johnson & Johnson
Market Cap: CL$366.8b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJCL
CL$154,000.00
7D
0%
1Y
-1.2%
Pfizer
Market Cap: CL$131.8b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFECL
CL$26,500.00
7D
0%
1Y
0.2%
Biogen
Market Cap: CL$18.7b
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
BIIBCL
CL$140,900.00
7D
0%
1Y
-46.0%
Amgen
Market Cap: US$149.7b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
US$255.16
7D
0%
1Y
0%
Biogen
Market Cap: US$18.7b
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
BIIB
US$245.00
7D
0%
1Y
0%
Gilead Sciences
Market Cap: US$134.9b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$89.71
7D
0%
1Y
36.9%